Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of PDE1B mRNA | decreases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of PDE1B mRNA | affects expression | 17562736
|
D003024 |
Clozapine |
Clozapine results in increased expression of PDE1B mRNA | increases expression | 14647396
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of PDE1B mRNA | increases expression | 14647396
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of PDE1B mRNA | increases expression | 18222493
|
D006220 |
Haloperidol |
Haloperidol results in increased expression of PDE1B protein | increases expression | 18222493
|
C044361 |
M-VAC protocol |
PDE1B protein results in increased susceptibility to M-VAC protocol | increases response to substance | 15814643
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of PDE1B mRNA | decreases expression | 16705456
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.92 | 3712494 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.47 | 16160616 14617031 12649775 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.36 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.13 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.13 | 19368416 18080171 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.54 | 11289319 1440618 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
2.93 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.93 | 3084413 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.80 | 7296757 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.37 | 15215559 1977408 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.75 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
2.96 | 7505956 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.38 | 19486331 9022650 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.17 | 15894690 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.38 | 17123785 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
5.19 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.90 | 11575062 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
3.21 | 12868966 11298694 18759878 11906362 2524372 8970840 14531868 8156756 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.84 | 2952479 3621924 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.06 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
3.03 | 16402076 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
6.07 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.67 | 18692083 18289764 8291058 9328219 7440962 1440618 9653073 9022650 16192314 6679447 6482804 11289319 18648102 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.67 | 18071297 16177239 17562736 17906064 10774834 11461765 10663392 19420014 2444490 19416960 11529661 19164858 12392966 14725611 11739529 16781746 19923254 19085960 14550746 12958197 16485898 16227642 12153990 12594235 10915739 14986274 11287661 15968718 12540782 11834606 12705907 15619225 18713872 16081117 11743745 11421492 19370779 19739265 16393943 17522070 16109766 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
6.67 | 15131321 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.62 | 19426721 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.40 | 16402076 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.17 | 3581430 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.54 | 6705139 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.19 | 16983495 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.39 | 7505956 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.89 | 6705139 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.95 | 16870215 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.37 | 16046005 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.36 | 15034207 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.47 | 14714311 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.54 | 8074119 9022650 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.36 | 15629191 12587719 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.23 | 6582329 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
4.18 | 17567588 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.38 | 15034207 9327722 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.69 | 16610002 19784758 12587719 16611625 11587558 12969438 19460945 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.54 | 16871587 17185352 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
2.71 | 3712494 598648 6587162 1399818 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.41 | 14737004 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.98 | 19513568 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
9.94 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
9.94 | 16856516 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.68 | 19142101 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.57 | 3581430 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
3.10 | 6679447 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.14 | 18514411 |
MESH:D009765 |
Obesity |
|
Clozapine |
3.07 | 19142110 18515891 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.72 | 4026338 6482804 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.54 | 3988306 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.65 | 16870215 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.90 | 7296757 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.99 | 6228378 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.34 | 18760546 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
5.37 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.90 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.90 | 11575062 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.61 | 3692021 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
4.22 | 20107430 20521320 20580759 17667964 20452607 17123785 17726453 19369910 11763009 16141801 18855531 11151749 20521326 20168265 18806925 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
4.22 | 20107430 18513383 1830565 19369910 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
5.09 | 20210726 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
3.12 | 6582329 7505956 3712494 1399818 6587162 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.37 | 8074119 |
MESH:D014571 |
Urologic Neoplasms |
|
M-VAC protocol |
6.54 | 17933135 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.33 | 10982225 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.75 | 16402076 16141801 20107430 20564506 17502770 20521320 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.54 | 17933447 |